Liang, W., Wu, X., Fang, W., Zhao, Y., Yang, Y., Hu, Z., . . . Zhang, L. (2014). Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationLiang, Wenhua, et al. Network Meta-analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-small-cell Lung Cancer Harboring EGFR Mutations. Public Library of Science (PLoS), 2014.
MLA (9th ed.) CitationLiang, Wenhua, et al. Network Meta-analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-small-cell Lung Cancer Harboring EGFR Mutations. Public Library of Science (PLoS), 2014.
Warning: These citations may not always be 100% accurate.